616 related articles for article (PubMed ID: 5132824)
1. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
2. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
3. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
4. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
5. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
6. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
Pierzchała W; Zamłyński J; Rzempołuch J
Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
[TBL] [Abstract][Full Text] [Related]
8. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
Hansen J; Andersen OS
Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
[No Abstract] [Full Text] [Related]
9. [Penicillamine in the treatment of Wilson's disease. Clinical picture].
Hauftová D; Hartl J; Seidlová V; Růzicková R; Kubĕna K; Slavícek J
Vnitr Lek; 1970 Apr; 16(4):337-43. PubMed ID: 5429582
[No Abstract] [Full Text] [Related]
10. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
Lange J
Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
[No Abstract] [Full Text] [Related]
11. [Treatment of Wilson's disease with zinc. 5 cases].
Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
[TBL] [Abstract][Full Text] [Related]
12. Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
Pasquali Ronchetti I; Quaglino D; Baccarani Contri M; Hayek J; Galassi G
J Submicrosc Cytol Pathol; 1989 Jan; 21(1):131-9. PubMed ID: 2702608
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of neurologic manifestations of Wilson's disease using penicillamine].
Hartl J; Hauftová D
Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217
[No Abstract] [Full Text] [Related]
14. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
Gregersen G; Frederiksen G
Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
[No Abstract] [Full Text] [Related]
15. [Wilson's disease treated by penicillamine: favorable effect].
Petit H
Lille Med; 1968 Dec; 13(10):1132-4. PubMed ID: 5711646
[No Abstract] [Full Text] [Related]
16. Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient.
Deguti MM; Mucenic M; Cancado EL; Tietge UJ
Am J Gastroenterol; 2002 Aug; 97(8):2153-4. PubMed ID: 12190204
[No Abstract] [Full Text] [Related]
17. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
19. [Electrophysiological changes of the brain in Wilson's disease under D-penicillamine treatment].
Fujita T; Fujita H; Okawa M; Yokoi S
Rinsho Shinkeigaku; 1976 May; 16(5):381-8. PubMed ID: 986276
[No Abstract] [Full Text] [Related]
20. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
